Dr. Siegal has obtained $1.9 million in peer-reviewed grant support as principal investigator or co-principal investigator from the Canadian Institutes of Health Research (CIHR), American Society of Hematology (ASH), Ontario AHSC AFP Innovation Fund, Heart and Stroke Foundation of Canada/CanVECTOR, Canadian Stroke Consortium/Brain Canada, TOHAMO, and Hamilton Health Sciences. She has received an additional $17 million of peer-reviewed grant funding as a co-investigator. 

Peer Reviewed Funding as Principal Investigator

Reducing Gastrointestinal Bleeding with Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism (RADIANT) Pilot Randomized Trial, CIHR Project Grant ($543,149) 2023-2026

Intensive Cancer Screening after Cryptogenic Stroke (INCOGNITO): Pilot Randomized Trial, OHRI ELEVATE Grant ($35,000) 2023-2024

Intensive Cancer Screening after Cryptogenic Stroke (INCOGNITO): Pilot Randomized Trial, TOHAMO Ontario AFP Innovation Grant ($87,088) 2023 – 2024 

Intensive Cancer Screening after Cryptogenic Stroke (INCOGNITO): Pilot Randomized Trial, Canadian Stroke Consortium/Brain Canada Catalyst Grant ($99,088) 2022 – 2023

Post-Bleed Management of Antithrombotic Therapy after Gastrointestinal Bleeding (PANTHER-GI): A Mixed-Methods Study of Patient Values and Preferences, Canadian Institutes of Health Research Fall 2020 Project Grant ($179,776) 2021 - 2023

Venous Thrombosis Virtual Surveillance in COVID (VVIRTUOSO), Canadian Institutes of Health Research COVID-19 Rapid Research Funding Opportunity ($303,658) 2020 - 2021

 Post-Bleed Management of Antithrombotic Therapy after Gastrointestinal Bleeding (PANTHER-GI): A Pilot Randomized Trial of Lower vs. Higher Dose Anticoagulation, American Society of Hematology Scholar Award ($150,000USD) 2020 - 2023

A Population Cohort Study to Evaluate the Risk of Ischemic Stroke, Stroke Treatments and Post-Stroke Outcomes Among Individuals with Cancer Compared to Matched Cancer-Free Controls, HAHSO Ontario AFP Innovation Grant ($94,570) 2020 - 2021

Peer-Reviewed Funding as Co-Investigator 

Understanding research priorities for Cerebral Venous Thrombosis, Canadian Institutes of Health Research Planning and Dissemination Grant, (PI: Field, $15,000) 2022

Timely Hip Fracture Care Pathway Implementation: A Feasibility Study - Orthopaedic Trauma Association Full Grant. (PI: Schneider, $65,000 USD) 2022

Antiplatelet Secondary Prevention International Randomised trial after INtracerebral haemorrhaGe: a pragmatic,randomised, parallel group, open, phase 3, international superiority trial -ASPIRING, Canadian Institutes of Health Research Project Grant (PI: Shoamanesh, $1,264,998) 2022 - 2028

Evaluating Individual Cancer-associated Thrombosis Mechanisms to Inform Personalized Thromboprophylaxis in Patients with Metastatic Bone Disease, Canadian Institutes of Health Research Project Grant (PI: Schneider, $1,043,615) 2022-2027

Hip Fracture Care Pathway for those on Oral Anticoagulation -Heart and Stroke Foundation of Canada Grant-in-Aid pilot implementation study (PI: Schneider, $266,900) 2022 - 2025

Evaluating Provincial Implementation of Timely Hip Fracture Care Pathways for Patients on Pre-injury Oral Anticoagulation -University of Calgary Pathways to Success Grant (PI: Schneider, $50,000) 2022 - 2025

HIP fracture thromboPROphylaxis (HIP PRO) Pilot: A Pilot Randomized Controlled Trial -Canadian Institutes of Health Research Project Grant (PI: Schneider, $577,575) 2022 - 2024

Strategies for Anticoagulation in patients with thrombocytopenia and cancer- associated Thrombosis -START pilot randomized controlled trial (PI: Wang/Carrier, $93,700) 2022 - 2023

Anticoagulation for stroke prevention in patients with recent episodes of perioperative atrial fibrillation after noncardiac surgery - The ASPIRE-AF study (PI: Conen, $4,639,726) 2021 - 2026

Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit, PAUSE-Virtual (PI: James/Douketis, $707,626) 2021 - 2024

Primary Thromboprophylaxis with Rivaroxaban in Patients with Malignancy and Central Venous Catheters: TRIM-Line, Canadian Institutes for Health Research Fall 2020 Project Grant (PI: Carrier, $1,850,000) 2021 - 2026

Catalyzing research innovation: Developing a web-based application with social media capabilities to coordinate thrombosis research efforts, New Frontiers in Research Fund - Exploration 2020 (PI: Skeith, $250,000) 2021 - 2023

CanVECTOR (Canadian Venous Thromboembolism Clinical Trials and Outcomes Research Network), Operating Grant: PANTHER, Canadian Institutes of Health Research (PI:Kahn/Rodger, $150,000) 2020 - 2021

Global assessment of hemostatic TGA indices following the use of prothrombin complex concentrates for major bleeding or urgent surgery in patients treated with factor Xa inhibitors (GAUGE) - a prospective observational cohort study (PI: Shaw/Carrier, $100,000) 2020 - 2022

Statins for Venous Event Reduction in patients with venous thromboembolism (The SAVER Trial), Project Grant, Canadian Institutes of Health Research (PI: Delluc/Rodger, $3,460,341) 2019 - 2024